IP
CLOV icon

Intellectus Partners’s Clover Health Investments CLOV Stock Holding History

Intellectus Partners’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,500
Closed -$48K – 256
2022
Q1 		$48K Buy
+13,500
New +$39.1K 0.01% 231
2021
Q4 		– Sell
-24,580
Closed -$182K – 277
2021
Q3 		$182K Buy
24,580
+1,250
+5% +$10.7K 0.04% 262
2021
Q2 		$311K Sell
23,330
-18,015
-44% -$177K 0.07% 229
2021
Q1 		$313K Buy
+41,345
New +$467K 0.09% 212

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Intellectus Partners's CLOV Position: Q2 2022 in Review

Intellectus Partners sold out of Clover Health Investments (CLOV) in Q2 2022, closing a stake of 13,500 shares — an estimated $48K sold.

Intellectus Partners first reported a position in CLOV in Q1 2021 and held it in 4 quarters. The position peaked at $313K in Q1 2021. 176 funds tracked by Wall St. Rank hold CLOV as of Q2 2022.

  • Intellectus Partners reported no remaining Clover Health Investments position as of Q2 2022 after selling out during the quarter.
  • Intellectus Partners sold 13,500 Clover Health Investments shares in Q2 2022, an estimated $48K.
  • Intellectus Partners first reported a position in Clover Health Investments in Q1 2021 and held it in 4 quarters.
  • Intellectus Partners's Clover Health Investments position peaked at $313K in Q1 2021.
  • 176 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2022.

Based on Intellectus Partners's 13F filing for Q2 2022, filed 12 Aug 2022.